Kavita Iyer

Scientific Content Creator and Writer, CAS

Bio

Kavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai in 2011. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, USA. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. Prior to joining CAS, she worked briefly at ACSII.

Drug Discovery

PPI inhibitors to fight cancer are making progress in clinical trials

Small molecule PPI inhibitors are on the brink of improving cancer treatments
|Article
Emerging Science

Co-occurring concepts reveal new research directions in immuno-oncology

Concept co-occurrence analysis shows the newest ideas in scientific discovery and drives innovation in immuno-oncology.
|Article
Drug Discovery

PROTACs are revolutionizing small molecule drug ​​development

PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
|Article
Biotechnology

Webinar: Big data insights in the quest to cure cancer

Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.
|Webinar
Drug Discovery

Emerging trends in immunotherapy and cancer

Immuno-oncology has the potential to treat cancer without sacrificing the patient's wellbeing.
|Article